SoftBank-Backed Biotech Roivant Climbs to $7 Billion Valuation

(Bloomberg) -- Roivant Sciences Ltd. raised $200 million in a new funding round that makes it one of the most highly valued private firms in the history of the biotechnology industry at $7 billion,...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.